1
Clinical Trials associated with CD4+CD25+CD127lowFoxP3+ T regulatory cells(Russian National Research Medical University)Phase 1 Pilot Study Using Autologous CD4+CD25+FoxP3+ T Regulatory Cells and Campath-1H to Induce Renal Transplant Tolerance
T regulatory cells (T regs) are responsible for immune tolerance in solid organ transplant patients. This study will evaluate the treatment of children with kidney transplants either with Campath and other immune system suppressing medications alone or in combination with injection of autologous CD4+CD25+CD127lowFoxP3+ T regulatory cells expanded ex vivo. The aim of this study is to develop a new strategy that will be more effective in preventing organ rejection and maintaining patient health.
100 Clinical Results associated with CD4+CD25+CD127lowFoxP3+ T regulatory cells(Russian National Research Medical University)
100 Translational Medicine associated with CD4+CD25+CD127lowFoxP3+ T regulatory cells(Russian National Research Medical University)
100 Patents (Medical) associated with CD4+CD25+CD127lowFoxP3+ T regulatory cells(Russian National Research Medical University)
100 Deals associated with CD4+CD25+CD127lowFoxP3+ T regulatory cells(Russian National Research Medical University)